|
Fomin V.V.
Can we manage arterial hypertension without hydrochlorothiazide?
|
№3 / 2009
|
|
M.V. Lebedeva, T.Yu. Stakhova, I.M. Balkarov, E.G. Minakova, L.I. Zaitseva, M.M. Severova, T.N. Shovskaya
Albuminuria, plasma endothelin-1 and carotid atherosclerosis in patients with arterial hypertension and hyperuricemia
|
№3 / 2009
|
|
G.P. Arutyunov, MD, PhD, Prof; L.G. Oganezova, MD
Beta-blockers and renal continuum
|
№2 / 2009
|
|
N.A. Moukhin, MD, PhD, Prof
Signs, mimicking chronic glomerulonephritis activity
|
№2 / 2009
|
|
M.M. Batiushin MD, PhD, Prof, E.S. Postnikova, MD, V.P. Terentiev MD, PhD, Prof, I.V. Dereviankina, MD
Correction of cerebro-renal syndrome in arterial hypertension with ischemic stroke: efficacy of eprosartan and hydrochlorothiazide
|
№1 / 2009
|
|
N.Yu. Borovkova, MD, N.N. Borovkov, MD, PhD, Prof, B.N. Sidnev, MD, E.O. Obuhova MD
Heart rate variability, plasma renin activity and aldosterone level in chronic glomerulonephritis with arterial hypertension and normal renal function
|
№1 / 2009
|
|
I.E. Chazova, MD., PhD., Prof; V.V. Fomin, MD., PhD.; E.M. Paltseva MD., PhD.
Direct renin inhibitor aliskiren – new opportunities of kidney protection at hypertensive patients
|
№1 / 2009
|
|
G.P. Arutyunov MD., PhD., Prof; L.G. Oganezova, MD (Moscow)
Hyperfiltration in clinical practise
|
№1 / 2009
|
Русский
